Jafron Biomedical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Cash & Equivalents	459.1	1,725	2,810	2,559	2,319	1,575
Trading Asset Securities	2,028	593.07	-	-	150.01	-
Cash & Short-Term Investments	2,487	2,318	2,810	2,559	2,469	1,575
Cash Growth	-8.37%	-17.52%	9.83%	3.62%	56.79%	23.85%
Accounts Receivable	35.46	55.61	81.21	239.64	308.06	215.8
Other Receivables	4.16	3.66	6.51	6.85	6.32	9.78
Receivables	39.62	59.27	87.72	246.49	314.37	225.58
Inventory	311.63	337.79	385	349.13	196.55	120.67
Prepaid Expenses	-	-	0.32	14.55	-	-
Other Current Assets	77.81	68.81	28.5	124.32	75.27	65.31
Total Current Assets	2,916	2,784	3,312	3,293	3,056	1,987
Property, Plant & Equipment	1,901	1,894	1,771	1,672	1,272	905.51
Long-Term Investments	117.37	446.13	116.13	69.45	111.2	98.99
Goodwill	7.01	7.01	12.21	37.81	44.07	44.07
Other Intangible Assets	97.4	97.75	100.37	100.43	101.31	89.89
Long-Term Deferred Tax Assets	57.38	34.97	30.35	36.49	26.54	12.97
Long-Term Deferred Charges	83.95	87.19	94.87	59	35.95	20.42
Other Long-Term Assets	356.58	32.35	107.03	148.22	162.91	58.22
Total Assets	5,536	5,383	5,543	5,417	4,810	3,217
Accounts Payable	99.82	119.19	135.62	128.52	60.76	50.22
Accrued Expenses	30.48	125.07	158.21	157.48	192.98	139.79
Short-Term Debt	58.42	77.51	261.83	317.09	-	-
Current Portion of Long-Term Debt	198.91	192.2	16.79	-	-	-
Current Portion of Leases	-	1.83	3.83	4.73	3.17	-
Current Income Taxes Payable	76.27	56.63	30.52	2.55	23.19	52.14
Current Unearned Revenue	22.3	16.86	37.57	42.3	20.65	26.95
Other Current Liabilities	198.99	177.51	185.03	64.52	85.51	61.73
Total Current Liabilities	685.21	766.79	829.42	717.18	386.26	330.82
Long-Term Debt	1,170	1,110	1,381	936.78	897.37	-
Long-Term Leases	4.48	4.74	11.35	17.34	17.01	-
Long-Term Unearned Revenue	221.38	144.95	151.78	151.66	125.08	51.7
Long-Term Deferred Tax Liabilities	21.97	16.11	16.78	3.12	0.73	0.54
Other Long-Term Liabilities	4.71	6	-	-	-	-
Total Liabilities	2,107	2,049	2,390	1,826	1,426	383.06
Common Stock	798.61	798.61	807.56	807.71	805.5	799.11
Additional Paid-In Capital	259.12	231.26	694.14	678.04	618	347.9
Retained Earnings	2,752	2,918	2,408	2,507	2,336	1,670
Treasury Stock	-500.07	-733.82	-880.63	-509.69	-523.8	-13.52
Comprehensive Income & Other	119.69	119.69	118.63	91.7	123.14	3.08
Total Common Equity	3,429	3,334	3,147	3,574	3,359	2,807
Minority Interest	-0.61	0.76	5.4	16.17	24.79	26.82
Shareholders' Equity	3,429	3,335	3,153	3,590	3,384	2,834
Total Liabilities & Equity	5,536	5,383	5,543	5,417	4,810	3,217
Total Debt	1,432	1,386	1,675	1,276	917.55	-
Net Cash (Debt)	1,055	931.31	1,135	1,283	1,552	1,575
Net Cash Growth	-3.74%	-17.97%	-11.49%	-17.34%	-1.47%	23.85%
Net Cash Per Share	1.38	1.19	1.43	1.62	1.93	1.94
Filing Date Shares Outstanding	774.36	774.36	774.47	798.87	815.46	798.53
Total Common Shares Outstanding	774.36	774.36	774.47	798.86	815.46	799.11
Working Capital	2,231	2,017	2,482	2,576	2,669	1,656
Book Value Per Share	4.43	4.31	4.06	4.47	4.12	3.51
Tangible Book Value	3,325	3,229	3,035	3,436	3,213	2,673
Tangible Book Value Per Share	4.29	4.17	3.92	4.30	3.94	3.34
Buildings	-	1,296	1,260	890.61	812.74	555.36
Machinery	-	764.58	678.23	514.6	304.98	212.71
Construction In Progress	-	244.45	122.43	473.99	301.15	262.68

Source: S&P Global Market Intelligence. Standard template. Financial Sources.